Why the study?
The Angiopoietin/Tie pathway regulates endothelial integrity and vascular stability, prompting an evaluation of these molecules as potential clinical biomarkers in vascular complications.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Angpt1/Tie2 signaling may regulate vascular leakage; leaves open whether pathway modulators improve clinical outcomes.
The Angiopoietin-1 (Angpt1)/Tie2 signaling pathway is important in regulating vascular function. Angpt1-induced Tie2 activation promotes vascular endothelial cell survival and reduces vascular leakage. Angiopoietin-2 (Angpt2), a weak agonist/antagonist of Tie2, opposes and regulates Angpt1 action. The Tie family of receptor tyrosine kinases, Tie2 and Tie1, exist as either homo-or heterodimers. The molecular complex between the receptors is also crucial in controlling Angpt1 signaling; hence, the molecular balance between Angpt1:Angpt2 and Tie2:Tie1 is important in determining endothelial integrity and vascular stability. This review presents evidence of the change observed in the Angiopoietin/Tie molecules in various pathophysiological conditions and discusses the potential clinical applications of these molecules in vascular complications.
No takes yet. Share an insight, caveat, or question.
Bilimoria et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: